Gilead Sciences antiviral shows promise as new treatment

A new study conducted by scientists at the University of Texas Medical Branch suggests that the antiviral drug obeldesivir may be effective in treating Ebola Sudan infections, for which there are currently no approved vaccines or treatments. The drug, given in pill form, showed promising results in primate tests, with all treated animals surviving. If…

Read More

Doctors’ industrial action: in search of an endgame

Kamran Abbasi, editor in chief of The BMJ, reflects on past strikes and the ongoing doctors’ strikes in the UK, highlighting the government’s unwillingness to negotiate meaningfully. He draws parallels between the treatment of miners in the 1980s and doctors today, emphasizing the importance of addressing issues beyond pay such as personal debt, training opportunities,…

Read More

Why do we usually sleep at night? What happens when we don’t sleep? Experts discuss sleep health

Sleep is crucial for overall health, with many restorative processes happening during sleep. We sleep at night due to our biological clock, and disruptions can lead to poor health outcomes like cognitive issues, high blood pressure, and diabetes. Not sleeping enough or poor quality sleep can affect mental health, and societal factors like electronic device…

Read More

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

Nuclera, a biotech company revolutionizing protein expression screening, has appointed Joseph Bertelsen as Chief Commercial Officer. With 20+ years in life science tools and drug development, Bertelsen brings valuable sales experience to drive adoption of Nuclera’s eProtein Discovery platform. Previously at the Institute for Protein Innovation, Diagenode, and Abcam, Bertelsen has a MSc in Pharmaceutical…

Read More

New Expert Recommendations on Pediatric Vitiligo Care

Topical calcineurin inhibitors (TCIs), topical corticosteroids (TCSs), and topical Janus kinase (JAK) inhibitors are recommended as mainstay treatments for children, adolescents, and young adults with vitiligo. Guidelines specifically addressing pediatric vitiligo management are lacking, so a protocol was established to create consensus recommendations. Topical therapies like TCIs and TCSs, as well as phototherapy, are important…

Read More

Zydus Lifesciences wins USFDA nod for Chlorpromazine Hydrochloride Injection for certain mental disorders

Zydus Lifesciences has received approval from the USFDA for their Chlorpromazine Hydrochloride Injection, which is used to treat certain mental disorders. The medication has been found effective in managing conditions such as schizophrenia and bipolar disorder. By obtaining this approval, Zydus Lifesciences has expanded their portfolio of mental health medications available in the United States….

Read More

Retina International World Congress comes to Dublin

The Retina International World Congress, one of the largest global gatherings of eye experts, will take place in Dublin in June at the Dublin Royal Convention Centre. The event will feature a scientific conference titled ‘Targeting the Cure: The Future of Vision Research’, with speakers including experts in gene therapy and ocular gene therapy. Professors…

Read More
error: Content is protected !!